Citations
89
22.3 per year
Published
2021
The rise and fall of hydroxychloroquine for the treatment and prevention of COVID-19
Expert Review of Anti-infective Therapy•2021
Authors
K Lee, JI Forrest, EJ Mills
COVID-19
Hydroxychloroquine
Abstract
The COVID-19 pandemic witnessed unprecedented interest in repurposing existing drugs for therapeutic use. Hydroxychloroquine emerged as an early candidate but subsequent evidence demonstrated limited efficacy. This review examines the trajectory of hydroxychloroquine research during the pandemic.
Related Publications
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
The Lancet Global Health • 2022
The Lancet
COVID-19
Effect of early treatment with ivermectin among patients with Covid-19
New England Journal of Medicine • 2022
COVID-19
Ivermectin
A real-time dashboard of clinical trials for COVID-19
The Lancet Digital Health • 2020
The Lancet
COVID-19